micro News and Research

RSS

Business update from Cardima

Cardima, Inc., a medical device company focused on the diagnosis and treatment of atrial fibrillation (“AF”), is providing the following update on its progress, recent activities and upcoming milestones.

12 Oct 2009

New technique may lead to more effective treatment for liver disease

A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.

12 Oct 2009

Xcelience's Xcelodose 120S precision powder micro-dosing system accelerates drug development

Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.

8 Oct 2009

U.S. Army renews mPhase Technologies' Phase II STTR grant

mPhase Technologies, Inc. announced today that their Phase II STTR Grant was renewed by the U.S. Army. The two year grant was initially awarded in September 2008 for the amount of $750,000. mPhase will continue to develop the Smart NanoBattery under this grant program through September 2010.

8 Oct 2009

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

Researchers at Case Western Reserve University School of Medicine have been awarded a $1.57 million renewal grant from the National Eye Institute (NEI) of the National Institutes of Health to continue their study of corneal infections, specifically, bacterial keratitis, associated with contact lens wear. The grant will extend the work initiated last year with the receipt of a $2.4 million, five-year grant from the NEI.

8 Oct 2009

Advanced Diamond Technologies unveils UNCD Horizon vapor-deposited diamond

Advanced Diamond Technologies, Inc. (ADT), announces the introduction of UNCD Horizon, the world’s smoothest vapor-deposited diamond, to its family of award-winning diamond products.

7 Oct 2009

New embolization technique offers better clinical outcomes in the treatment of liver cancer

The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.

6 Oct 2009

ThromboGenics presents Phase IIa microplasmin intravitreal injection trial results at the ASRS conference

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).

6 Oct 2009

PDT-PCI combination with ENVIRON Surgical Roll-CIT effective for treating facial acne scars

The appearance of facial acne scars showed greater improvement with a combination treatment of photodynamic therapy (PDT) and percutaneous collagen induction (PCI or medical needling) with the ENVIRON® Surgical Roll-CIT(TM) compared to PDT alone.

5 Oct 2009

Pharmatek to install the Xcelodose automated encapsulator system in San Diego

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it is the first CRO on the West Coast to acquire the Xcelodose system, enhancing the company's preclinical and early phase clinical GMP supply capabilities.

3 Oct 2009

Enzyme that helps make tuberculosis resistant to a human's natural defense system identified

Researchers at Iowa State University have identified an enzyme that helps make tuberculosis resistant to a human's natural defense system. Researchers have also found a method to possibly neutralize that enzyme, which may someday lead to a cure for tuberculosis.

3 Oct 2009

Stellartech and Orthomems to design and develop external reader device

Stellartech, a world leader in the design, development and contract manufacture of sophisticated medical systems, and OrthoMEMS, a medical device company focused on biomedical applications of patented MEMS (micro-electro-mechanical systems) and wireless technology from Cleveland Clinic, today announced a strategic alliance that is set to deliver a groundbreaking, commercial reader for wireless communication with a miniature implanted sensor in the spine.

1 Oct 2009

Stanford Hospital invests $3 million in technology for safe patient handling

Swaddled in a cushy green hammock, the patient began her ascent off the bed. While one nurse regulated the speed of the lifting device, two of his colleagues guided the patient toward a bedside chair. Within seconds, she was securely lowered onto a cushion, and ready to begin rehabilitation exercises.

1 Oct 2009

Immunocellular Therapeutics' pilot study can help in early cancer detection

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.

30 Sep 2009

Hitachi High-Technologies reaches milestone: More than 1000 units of TM-1000 shipped

Hitachi High-Technologies Corporation (TOKYO:8036) today announced that cumulative shipments of the tabletop microscope TM-1000, launched in April 2005, have now surpassed 1,000 units.

30 Sep 2009

Seminar to focus on clean technologies

Technologies like nanotechnology, biomaterials and microfluidics can play a powerful role in reducing the impact of industrial activity on the environment, while opening new markets for Alberta-developed products and services.

30 Sep 2009

Hygafem's hand sanitizing program launched at Morehouse College

Hygafem, Inc., the Georgia-based premier provider of touch-free workplace wellness technologies and services, has successfully launched its hand sanitizing program at Morehouse College in Atlanta, GA. Hygafem’s touch-free hand sanitizing program decreases the risk of spreading disease, ensures safe and healthy facilities, and boosts satisfaction for students and employees at Morehouse College.

29 Sep 2009

Secretary of State Clinton announces food security initiative

Secretary of State Hillary Rodham Clinton on Friday "unveiled … a food security initiative launched by the Obama administration to combat hunger worldwide," the Associated Press reports.

28 Sep 2009

Millennium Foundation announces fundraising initiative for global health

The Millennium Foundation for Innovative Finance for Health today announced MASSIVEGOOD, a new, innovative travel-related fundraising initiative that will help finance health care for the world's poor.

26 Sep 2009

NSF funds UAB to purchase highly-specialized imaging system

The National Science Foundation has awarded $431,200 to the University of Alabama at Birmingham (UAB) Department of Physics to facilitate the purchase of a new highly-specialized imaging system - the first of its kind in Alabama - that will be a centerpiece of a new interdisciplinary research laboratory on campus.

26 Sep 2009